Retrospective cross-sectional study identifies increased hematocrit as a risk factor for cranial MRI abnormalities in neonates, suggesting its potential as a biomarker.
Key Points
Higher hematocrit levels correlate with an increased risk of cranial MRI abnormalities in neonates with hyperbilirubinemia.
Multivariate logistic regression reveals that each 1% increase in hematocrit raises the risk of abnormalities by 6%.
The study utilized a retrospective cross-sectional analysis of 410 neonates, examining blood parameters and MRI findings.
These findings indicate that hematocrit may serve as an important risk factor for detecting cranial MRI abnormalities.